Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case–control study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case–control study ; volume:15 ; number:1 ; day:3 ; month:4 ; year:2015 ; pages:1-8 ; date:12.2015
BMC psychiatry ; 15, Heft 1 (3.4.2015), 1-8, 12.2015
- Urheber
-
Jorgensen, Anders
- Beteiligte Personen und Organisationen
-
Knorr, Ulla
Soendergaard, Mia Greisen
Lykkesfeldt, Jens
Fink-Jensen, Anders
Enghusen Poulsen, Henrik
Jorgensen, Martin Balslev
Vidiendal Olsen, Niels
Staalsø, Jonatan Myrup
SpringerLink (Online service)
- DOI
-
10.1186/s12888-015-0455-4
- URN
-
urn:nbn:de:1111-2016110920586
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jorgensen, Anders
- Knorr, Ulla
- Soendergaard, Mia Greisen
- Lykkesfeldt, Jens
- Fink-Jensen, Anders
- Enghusen Poulsen, Henrik
- Jorgensen, Martin Balslev
- Vidiendal Olsen, Niels
- Staalsø, Jonatan Myrup
- SpringerLink (Online service)
Ähnliche Objekte (12)
Atypical antipsychotics
Diabetes and atypical antipsychotics
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
Clinical pharmacology of atypical antipsychotics: an update
Atypical antipsychotics in the treatment of schizophrenic patients
Diabetic control and atypical antipsychotics: a case report
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
Atypical antipsychotics
Diabetes and atypical antipsychotics
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
Clinical pharmacology of atypical antipsychotics: an update
Atypical antipsychotics in the treatment of schizophrenic patients
Diabetic control and atypical antipsychotics: a case report
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
Atypical antipsychotics
Diabetes and atypical antipsychotics
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
Clinical pharmacology of atypical antipsychotics: an update
Atypical antipsychotics in the treatment of schizophrenic patients
Diabetic control and atypical antipsychotics: a case report